Open Your FREE Demat Account Now!

Haleos Labs Ltd. Share Price

NSE
BSE

NSE : HALEOSLABS

BSE : 540679

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹1,419.40

High

₹1,571.10

Price Summary

Previous Close ₹1,570.90
Day's Range ₹1,419.40 - ₹1,571.10
Open ₹1,422.40
52 Week Range ₹1,091.10 - ₹1,774.00
Volume 4,265
Market Cap ₹0.00
Previous Close ₹1,600.00
Day's Range ₹1,425.00 - ₹1,600.00
Open ₹1,425.00
52 Week Range ₹1,181.00 - ₹1,778.35
Volume 13
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 67.00
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.11
Price/Earning (TTM) 26.40
TTM EPS (₹) 52.27
P/E Ratio 20.95
Book Value(₹) 1.94
PAT Margin (%) 4.68
Face Value (₹) 10.00
ROCE(%) 10.53
Trade Value ( ₹ in Lacs) 0.21
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.11
Price/Earning (TTM) 26.40
TTM EPS (₹) 52.27
P/E Ratio 20.95
Book Value(₹) 1.94
PAT Margin (%) 4.68
Face Value (₹) 10.00
ROCE(%) 10.53

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 790.43 3333.71
Expenses N/A N/A
PBT 74.78 300.41
Operating profit 0.0 0.0
Net profit 51.58 213.71

Shareholding Pattern

Promoters (% Holding)

72.11%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

27.58%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Haleos Labs Ltd.

Founded 2006
Managing Director TVVSN Murthy
NSE Symbol HALEOSLABS

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,54,913.91 1,884.80 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 3,00,380.35 11,413.50 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,81,169.21 4,746.45 3,672.30 - 3,672.30
Laurus Labs Ltd. 1,31,566.03 2,419.00 917.95 - 917.95
Lenskart Solutions Ltd. 1,25,837.35 734.30 0.00 - 0.00
Apollo Hospitals Enterprise Ltd. 1,23,511.02 8,508.00 6,696.50 - 6,696.50
Zydus Lifesciences Ltd. 1,18,712.93 1,204.95 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,14,933.37 1,382.05 1,101.00 - 1,101.00
Cipla Ltd. 1,14,477.74 1,413.70 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,09,746.08 2,640.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Sep
21
2026
EQUITY Posted on Sep 21st 2026

Haleos Labs informs about closure of trading window

Haleos Labs has informed that ‘Trading Window’ for dealing in securities of the Company for Designated Persons and specified Connected Persons (including their Immediate relatives) of the Company and Subsidiary of the Company, shall remain closed with effect from October 1, 2026 till 48 hours after the declaration of financial results for quarter and half year ended sept 30, 2026, In terms of the ‘Code of Conduct for Prevention of Insider Trading’ of the Company. Date of the Board meeting for considering the unaudited financial results Of the Company for the quarter and half year ended September 30, 2026, will be informed separately in due course. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
1
2026
EQUITY Posted on Sep 1st 2026

Haleos Labs informs about outcome of postal ballot

Haleos Labs has informed that the Company has conducted the Postal Ballot process for seeking approval of its shareholders, by way of Postal Ballot voting (only through e-voting, for the following resolutions as set out in the Postal Ballot Notice dated May 29, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
1
2026
EQUITY Posted on Sep 1st 2026

Haleos Labs informs about postal ballot result

Haleos Labs has informed that the Company has conducted the Postal Ballot process for seeking approval of its shareholders, by way of Postal Ballot voting (only through e-voting), for the resolutions as set out in the Postal Ballot Notice dated May 29, 2026. Details enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Aurobindo Pharma informs about unaudited financial results

Aurobindo Pharma has informed that it enclosed the transcript of the said earnings call on the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2026 and the same is being uploaded on the website of the Company and is available at the following web link. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/conference-calltranscripts.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Gujarat Kidney & Superspeciality informs about transcript of earnings call

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Kidney & Superspeciality has informed that it enclosed the transcript of the Earnings call with Analysts / Investors held on Thursday, November 05, 2026, post declaration of the Financial Results for the quarter and half year ended September 30, 2026. The same has also been disseminated on the website of the Company. 

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Haleos Labs Ltd. ?

The current share price of Haleos Labs Ltd. is ₹1,570.90 as of 2026-11-12.

The market capitalisation of Haleos Labs Ltd. is ₹417.21 as of 2026-11-11.

The 1-year return of Haleos Labs Ltd. is % as of .

The P/E ratio of Haleos Labs Ltd. is 20.95 as of 2026-11-12.

The 52-week high and low of Haleos Labs Ltd. are ₹1,774.00 and ₹1,091.10, respectively, as of 2026-11-12.

The dividend yield of Haleos Labs Ltd. is 0.1087% as of2026-11-11.

You can buy Haleos Labs Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Haleos Labs Ltd. is TVVSN Murthy.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore